Clinical Trial Update: MSC Therapy in Liver Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update investigating mesenchymal stem cell therapy for liver transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Rejection

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Monia Lorini | Conditions: Liver Transplant Rejection | Phase 1 | Status: UNKNOWN